All AbMole products are for research use only, cannot be used for human consumption.
HA Peptide (HA tag) is a nine amino acids peptide derived from the human influenza hemagglutinin (HA). HA Peptide is extensively used to isolate, purify, detect, and track the protein of interest in cell biology and biochemistry.
| Molecular Weight | 1102.15 |
| CAS Number | 92000-76-5 |
| Solubility (25°C) | Water 50 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[3] Yan Yang, et al. A novel hydroxyapatite-binding antimicrobial peptide against oral biofilms
| Related Peptides Products |
|---|
| Amylin amide, human TFA
Amylin amide, human TFA is a 37-amino acid polypeptide, it is a pancreatic hormone cosecreted with insulin that exerts unique roles in metabolism and glucose homeostasis. Amylin amide, human TFA inhibits glucagon secretion, delays gastric emptying. |
| WL47 TFA
WL47 TFA, a high-affinity cavolin-1 (CAV1) ligand (Kd=23 nM), is a potent disrupter of CAV1 oligomers. WL47 TFA shows selectivity for CAV1 over BSA, casein and HEWL. WL47 TFA can be used for the study of caveolin-1 function. |
| Angiopep-2-Cys TFA
Angiopep-2-cys is a conjugate of Angiopep-2 hydrochloride and cysteine. The conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer. |
| H3K4(Me2) (1-20)
H3K4(Me2) (1-20) is a histone peptide. H3K4me2 regulates the recovery of protein biosynthesis and homeostasis following DNA damage. |
| Elcatonin
Elcatonin is a synthetic analog of eel calcitonin that increases bone density and inhibits bone resorption. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
